Rakuten Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	$316K	Buy	+2,794	New	+$316K	﹤0.01%	622
2024 Q3	$212K	Buy	1,841 +472	+34%	+$54.3K	﹤0.01%	488
2024 Q2	$184K	Buy	1,369 +519	+61%	+$69.7K	﹤0.01%	475
2024 Q1	$117K	Buy	850 +780	+1,114%	+$108K	﹤0.01%	471
2023 Q4	$9.25K	Buy	+70	New	+$9.25K	﹤0.01%	486